For research use only. Not for therapeutic Use.
Xeligekimab (GR 1501) is an anti-human interleukin 17A (IL-17A) humanized monoclonal antibody. Xeligekimab inhibits the pro-inflammatory cascade[1].
| Catalog Number | I041612 |
| CAS Number | 2382921-73-3 |
| Purity | ≥95% |
| Reference | [1]. Sen R, et, al. Current treatment and molecular targets for axial spondyloarthritis: Evidence from randomized controlled trials. Curr Opin Pharmacol. 2022 Dec;67:102307. |
